Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pneumococcal histidine triad protein D is an essential surface antigen involved primarily in zinc uptake and immune evasion mechanisms of S. pneumoniae. Its strong conservation across strains and ability to induce broad protective immunity make it an attractive target for next-generation universal pneumococcal vaccines.
Antibodies against PhtD facilitate pneumococcal clearance through complement- and macrophage-dependent opsonophagocytosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pneumococcal histidine triad protein D (PhtD).